Page last updated: 2024-10-28

idebenone and Stroke

idebenone has been researched along with Stroke in 3 studies

Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Research Excerpts

ExcerptRelevanceReference
"A 38-year-old patient with MELAS and SLEs was treated with oral L-arginine and idebenone for 27months."7.77Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient. ( Cho, TH; Derex, L; Kouamé-Assouan, AE; Lekoubou, A; Luauté, J; Nighoghossian, N, 2011)
"Idebenone is a well-appreciated mitochondrial protectant while the mechanisms underlying the neuroprotection in cerebral ischemia and reperfusion (I/R) remain elusive."3.96Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity. ( Gong, Z; He, L; Li, X; Pan, J; Peng, J; Peng, Y; Shen, Q; Wang, H, 2020)
"An aim of the study was to assess the severity of asthenic syndrome, emotional disorders and quality of life indicators in post stroke patients treated with idebenone (noben)."3.79[Emotional disorders and quality of life in patients with post stroke asthenia]. ( Boĭko, AN; Ismailov, AM; Khozova, AA; Lebedeva, AV; Petrov, SV; Shchukin, IA; Shikhkerimov, RK; Soldatov, MA, 2013)
"A 38-year-old patient with MELAS and SLEs was treated with oral L-arginine and idebenone for 27months."3.77Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient. ( Cho, TH; Derex, L; Kouamé-Assouan, AE; Lekoubou, A; Luauté, J; Nighoghossian, N, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Peng, J1
Wang, H1
Gong, Z1
Li, X1
He, L1
Shen, Q1
Pan, J1
Peng, Y1
Boĭko, AN1
Lebedeva, AV1
Shchukin, IA1
Soldatov, MA1
Petrov, SV1
Khozova, AA1
Ismailov, AM1
Shikhkerimov, RK1
Lekoubou, A1
Kouamé-Assouan, AE1
Cho, TH1
Luauté, J1
Nighoghossian, N1
Derex, L1

Other Studies

3 other studies available for idebenone and Stroke

ArticleYear
Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity.
    Molecular immunology, 2020, Volume: 123

    Topics: Animals; Animals, Newborn; Brain Ischemia; Cells, Cultured; Encephalitis; Inflammasomes; Male; Mice;

2020
[Emotional disorders and quality of life in patients with post stroke asthenia].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2013, Volume: 113, Issue:11

    Topics: Affective Symptoms; Aged; Aged, 80 and over; Antioxidants; Female; Humans; Male; Middle Aged; Qualit

2013
Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient.
    Revue neurologique, 2011, Volume: 167, Issue:11

    Topics: Administration, Oral; Adult; Antioxidants; Arginine; Drug Combinations; Female; Humans; MELAS Syndro

2011